April 14, 2008 — /Newton, MA/ — Microfluidics, a wholly owned subsidiary of MFIC Corporation, announces methods for processing bulk carbon nanotubes. Microfluidics has devised a methodology to process, deagglomerate, purify, and stabilize these processed nanotubes so they can be used in an optimal manner, thus achieving enhanced functionality and performance.
The company has identified and demonstrated numerous operational protocols utilizing its MicrofluidizerR processor systems to prepare these bulk nanotubes for their ultimate specific uses. These applications capitalize on the unique mechanical, electrical, and thermal properties of carbon nanotubes and require dispersion of the nanotubes in liquid media and independent length reduction of the carbon nanotubes.
Carbon nanotubes are noted for their tubular shape, extremely small diameter with respect to length, and exceptional physical, mechanical, and electrical properties. When prepared in diameters in the 10 to 50-nm range, the unique characteristics of strength, conductivity, and quantum behavior become highly desirable and are thus incorporated into a multitude of commercial products.
Microfluidizer processors are ideal for conditioning carbon nanotubes -and nanomaterials in general- for applications that include high tensile strength polymers, fabric treatments, lubricants, medical therapeutics, computer memory and chips, electronic devices, medical diagnostic biolabels, and photovoltaic cell components.
Microfluidics, a wholly owned subsidiary of MFIC Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale, and manufacturing applications. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products and produces the most uniform and smallest liquid and suspended solid particles available.
Microfluidics has been a worldwide supplier of Microfluidizer high shear fluid processing systems to the biotechnology, pharmaceutical, chemical, cosmetics/personal care, and food industries since 1984. As leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate, and produce licensed drugs for the worldwide healthcare market.